๐ŸŽ Black Friday: 50% off Unlimited and 30% off Pro annual plans
ImmunityBio, Inc. (IBRX)
NASDAQ: IBRX ยท Real-Time Price ยท USD
6.70
+0.44 (7.03%)
At close: Nov 18, 2026, 4:00 PM EST
6.70
0.00 (0.00%)
Pre-market: Nov 19, 2026, 8:37 AM EST

ImmunityBio Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
182.57113.2914.750.620.240.93
Revenue Growth
121.15%668.32%2270.58%159.17%-74.30%54.38%
Gross Profit
180.36112.5414.750.620.240.93
Operating Income
-274.16-256.03-344.18-361.36-350.67-317.42
Net Income
-1,110-351.4-413.56-583.2-416.57-346.79
Earnings Per Share
-1.08-0.38-0.62-1.15-1.04-0.89
EPS Growth
------

Revenue by Segment

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Product
181.85112.9814.15---
Other
0.720.310.60.620.240.93
Revenue (Total)
182.57113.2914.750.620.240.93

Cash & Debt

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
334.33242.82149.81267.35108.02317.94
Total Debt
1,296844.72789.82883.68725.33648.26
Net Cash (Debt)
-961.77-601.9-640.01-616.32-617.31-330.32
Net Cash Growth
------
Net Cash Per Share
-0.93-0.65-0.91-1.21-1.54-0.85

Cash Flow & CapEx

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-287.56-304.94-391.24-366.76-337.51-274.42
Capital Expenditures
-9.12-3.85-6.89-30.58-78.16-33.56
Free Cash Flow
-296.69-308.78-398.12-397.34-415.67-307.98
Free Cash Flow Growth
------

Margins

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
98.79%99.33%100.00%100.00%100.00%100.00%
Operating Margin
-150.16%-226.00%-2334.23%-58097.11%-146111.67%-33985.44%
Pretax Margin
-607.89%-310.37%-2805.32%-93873.31%-173869.17%-37456.00%
Profit Margin
-607.79%-310.18%-2804.77%-93761.41%-173569.58%-37129.55%
FCF Margin
-162.50%-272.56%-2700.06%-63881.19%-173196.25%-32974.52%

Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingNov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
39.0417.22126.775388.888648.472589.53